LPL Financial »

Xilio Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 31k 0.84
2025-06-30 $21k 31k 0.68

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics